Welcome to our dedicated page for Clarivate news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate stock.
Clarivate Plc reports developments in data, analytics and workflow software for academia and government, intellectual property, and life sciences and healthcare. Its news commonly covers earnings, subscription and recurring revenue trends, cash flow and leverage actions, and progress under its operating improvement initiatives.
Company updates also focus on AI-enabled research and decision-support products, including Web of Science Research Intelligence, Nexus Connect, Cortellis Regulatory Intelligence, Derwent-based patent analytics and other Clarivate data assets. Recurring announcements address institutional research intelligence, academic library workflows, regulatory intelligence for life sciences teams, intellectual property benchmarks and investor conference appearances.
Clarivate (NYSE: CLVT) appointed Michael Easton as Executive Vice President and Chief Financial Officer, effective August 8, 2026. He succeeds Jonathan Collins, who is stepping down as CFO to pursue another opportunity.
Easton has over 25 years of finance, accounting and operations experience and most recently served as Senior Vice President and Chief Accounting Officer, overseeing Clarivate’s core financial reporting and planning functions. As CFO, he will focus on accelerating growth, improving profitability, strengthening free cash flow generation and maintaining disciplined capital allocation. Clarivate also reported its second quarter 2026 financial results in a separate release and will host a webcast at 9:30 AM Eastern Time to review them.
Clarivate (NYSE: CLVT) reported second quarter 2026 revenues of $587.3 million, down 5.5% year over year, with organic revenues declining 1.5% as 0.7% organic subscription growth was offset by weaker transactional activity. Net loss widened to $268.6 million ($0.42/share), primarily due to a $221.7 million non-cash goodwill impairment.
Adjusted net income was $123.1 million and Adjusted EBITDA $247.2 million. For the first half, revenue was $1.17 billion, Adjusted EBITDA $488.4 million, and free cash flow $122.9 million. Total debt fell by $218.4 million to $4.25 billion. Clarivate highlighted progress on its Value Creation Plan, the previously announced Life Sciences & Healthcare divestiture, and reaffirmed its 2026 outlook, including revenue of $2.30–$2.42 billion and Adjusted EBITDA of $980 million–$1.04 billion.
Clarivate (NYSE: CLVT) announced that its AI-powered trademark risk assessment solution RiskMark has won the 2026 CODiE Award for Best AI Tool for Lawyers. Launched in 2025, RiskMark uses predictive and generative AI on 172.5 million trademark records and over five million decisions to help legal professionals evaluate trademark confusion and risk quickly and reliably.
Clarivate (NYSE: CLVT) is providing AI-assisted image search technology to power a new image search capability in the U.S. Patent and Trademark Office’s TM Search trademark system. Users can now upload images and compare them against the U.S. trademark register to help identify visually similar existing marks, improving search efficiency and result quality.
Clarivate (NYSE:CLVT) announced that France’s Bibliographic Agency for Higher Education (Abes) has selected it, under a multi-year agreement, to modernize the national academic library system using a shared, cloud-based platform built on Alma, Primo and Rapido.
The solution will unify library services, resource sharing and AI-powered discovery, replacing legacy systems for the national union catalog and interlibrary loans across a network of 3,000 libraries and over 15 million bibliographic records. Abes cited pragmatic reasons, value for money and improved service quality in a constrained economic context. The deal adds to Clarivate’s existing support for more than 70 French academic institutions.
Clarivate (NYSE: CLVT) will report its second quarter 2026 financial results before market open on Wednesday, July 29, 2026. The earnings press release and supplement will be posted on the Clarivate investor website, followed by a conference call and webcast at 9:30 AM Eastern Time.
Clarivate (NYSE: CLVT) agreed to sell its Life Sciences & Healthcare segment to Altaris for $600 million, refocusing on its Academia & Government and Intellectual Property businesses. The company plans to use cash proceeds to reduce debt and reaffirmed its full-year 2026 outlook, including LS&H as discontinued operations.
Consideration includes $500M cash at closing, $25M deferred, and a $75M seller note. Clarivate expects a $225–$250M non-cash goodwill impairment on LS&H that will not affect its 2026 outlook metrics.
Clarivate (NYSE:CLVT) released its 2025 Sustainability Report, outlining progress on environmental and social goals. Total reported greenhouse gas emissions across Scopes 1, 2 and 3 fell 24%, from 96,666 tCO₂e in 2024 to 73,110 tCO₂e in 2025.
Other highlights include sustainability-certified workplaces now covering about 38% of total square footage, ProQuest One Sustainability adoption by 400+ institutions, more than 36,000 volunteer hours contributed, and collaboration with Teva on antimicrobial stewardship programs in Germany and Kenya.
Clarivate (NYSE: CLVT) released the Journal Citation Reports 2026, providing publisher-neutral metrics for 22,643 journals across 254 categories. The edition reflects 2025 data and emphasizes transparency, consistency and responsible use of journal indicators.
Key trends include expanded global participation, rising Global South representation and field-normalized metrics that support contextual, discipline-aware journal evaluation.
Clarivate (NYSE:CLVT) announced that Mitsubishi Fuso Truck and Bus Corporation has selected IPfolio as its cloud-based intellectual property management solution. The platform combines trusted data, expert support, and integrated services to centralize patents, trademarks, and other IP information and support IP-focused digital transformation.
According to Clarivate, IPfolio offers automated data verification using Derwent patent data, dashboards for visualization, integrated annuity and renewal management, and live system configuration, aiming to streamline processes, improve data accuracy, and support faster, better-informed IP decisions. Implementation will be supported by Clarivate teams in Japan.